-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
SCPS:OTC-Scopus Biopharma Inc (USD)
COMMON STOCK | Biotechnology |
Last Closing
USD 0.0001Change
0.00 (0.00)%Market Cap
USD 4.21KVolume
N/AVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Biotechnology |
Last Closing
USD 0.0001Change
0.00 (0.00)%Market Cap
USD 4.21KVolume
N/AVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
NONOF | Novo Nordisk A/S |
N/A |
USD 641.36B |
CMXHF | CSL Limited |
N/A |
USD 95.97B |
CSLLY | CSL Ltd |
N/A |
USD 95.20B |
UCBJF | UCB SA |
N/A |
USD 28.35B |
UCBJY | UCB SA ADR |
N/A |
USD 27.94B |
ARGNF | argenx SE |
N/A |
USD 23.04B |
GNMSF | Genmab A/S |
N/A |
USD 16.66B |
IVBIY | IVBIY |
N/A |
USD 8.23B |
SBMFF | Sino Biopharmaceutical Limited |
N/A |
USD 6.87B |
REGMF | RemeGen Co. Ltd |
N/A |
USD 6.81B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
IEO | 19.11 % | 0.42 % |
N/A |
N/A | |
IOGP:LSE | iShares Oil & Gas Explora.. | 10.20 % | 0.00 % |
N/A |
USD 0.32B |
SPOG:LSE | iShares V Public Limited .. | 10.20 % | 0.00 % |
N/A |
USD 0.32B |
NRGD | MicroSectors U.S. Big Oil.. | 10.00 % | 0.00 % |
N/A |
USD 0.09B |
NRGU | MicroSectors U.S. Big Oil.. | 10.00 % | 0.00 % |
N/A |
USD 1.79B |
NRGO | 10.00 % | 0.00 % |
N/A |
N/A | |
NRGZ | 10.00 % | 0.00 % |
N/A |
N/A | |
YGRN | 10.00 % | 0.00 % |
N/A |
N/A | |
FRAK | 8.73 % | 0.54 % |
N/A |
N/A | |
IESU:LSE | iShares S&P 500 Energy Se.. | 8.04 % | 0.00 % |
N/A |
USD 0.98B |
IUES:LSE | iShares S&P 500 Energy Se.. | 8.01 % | 0.00 % |
N/A |
USD 0.95B |
IUSE:LSE | iShares S&P 500 EUR Hedge.. | 8.01 % | 0.00 % |
N/A |
USD 5.77B |
XSEN:LSE | db x-trackers MSCI USA En.. | 7.57 % | 0.00 % |
N/A |
USD 0.07B |
XUEN:LSE | db x-trackers MSCI USA En.. | 7.57 % | 0.00 % |
N/A |
USD 0.07B |
FTXN | First Trust Nasdaq Oil & .. | 7.51 % | 0.60 % |
N/A |
USD 0.21B |
JHME | 6.90 % | 0.48 % |
N/A |
N/A | |
OILD | MicroSectorsTM Oil & Gas .. | 6.84 % | 1.24 % |
N/A |
USD 0.02B |
FENY | Fidelity® MSCI Energy In.. | 6.73 % | 0.08 % |
N/A |
USD 1.77B |
OILU | MicroSectorsTM Oil & Gas .. | 6.46 % | 1.22 % |
N/A |
USD 0.05B |
DDG | 5.83 % | 0.95 % |
N/A |
N/A | |
DUG | ProShares UltraShort Oil .. | 5.83 % | 0.95 % |
N/A |
USD 0.01B |
FILL | iShares MSCI Global Energ.. | 4.81 % | 0.39 % |
N/A |
USD 0.11B |
ERYY | 4.79 % | 0.45 % |
N/A |
N/A | |
WNRG:LSE | SPDR MSCI World Energy UC.. | 4.78 % | 0.00 % |
N/A |
USD 0.57B |
XDW0:LSE | db x-trackers MSCI World .. | 4.76 % | 0.00 % |
N/A |
USD 1.12B |
IGE | 4.54 % | 0.46 % |
N/A |
N/A | |
IXC | iShares Global Energy ETF | 4.51 % | 0.46 % |
N/A |
USD 2.34B |
HUL-U:CA | 4.46 % | 0.00 % |
N/A |
N/A | |
HUL:CA | 4.46 % | 2.20 % |
N/A |
N/A | |
FCG | First Trust Natural Gas E.. | 4.39 % | 0.60 % |
N/A |
USD 0.40B |
GASX | 4.29 % | 1.01 % |
N/A |
N/A | |
SXLE:LSE | SPDR S&P U.S. Energy Sele.. | 4.25 % | 0.00 % |
N/A |
USD 0.94B |
NANR | SPDR S&P® North American.. | 4.09 % | 0.35 % |
N/A |
USD 0.53B |
ERX | Direxion Daily Energy Bul.. | 2.93 % | 1.08 % |
N/A |
USD 0.33B |
FCQH:CA | Fidelity U.S. High Qualit.. | 2.75 % | 0.43 % |
N/A |
CAD 0.06B |
HEA:CA | Horizons Enhanced Income .. | 2.61 % | 0.00 % |
N/A |
CAD 0.16B |
HEA-U:CA | Horizons Enhanced Income .. | 2.61 % | 0.00 % |
N/A |
CAD 0.03B |
FCUQ:CA | Fidelity U.S. High Qualit.. | 2.44 % | 0.00 % |
N/A |
CAD 0.55B |
SPGP | Invesco S&P 500 GARP ETF | 2.10 % | 0.36 % |
N/A |
USD 6.26B |
GASL | 1.45 % | 1.19 % |
N/A |
N/A | |
GUSH | Direxion Daily S&P Oil & .. | 1.40 % | 1.04 % |
N/A |
USD 0.39B |
EQWL | Invesco S&P 100 Equal Wei.. | 1.03 % | 0.25 % |
N/A |
USD 0.69B |
TERM | 0.88 % | 0.64 % |
N/A |
N/A | |
JIGB | JPMorgan Corporate Bond R.. | 0.39 % | 0.14 % |
N/A |
USD 0.05B |
SCHJ | Schwab 1-5 Year Corporate.. | 0.09 % | 0.00 % |
N/A |
USD 0.41B |
BWX | SPDR® Bloomberg Internat.. | 0.00 % | 0.50 % |
N/A |
USD 0.86B |
EBND | SPDR® Bloomberg Emerging.. | 0.00 % | 0.41 % |
N/A |
USD 1.91B |
MTUM | 0.00 % | 0.15 % |
N/A |
N/A | |
QUAL | 0.00 % | 0.15 % |
N/A |
N/A | |
TGED:CA | TD Active Global Enhanced.. | 0.00 % | 0.00 % |
N/A |
CAD 0.27B |
RYE | 0.00 % | 0.40 % |
N/A |
N/A | |
WIP | SPDR® FTSE International.. | 0.00 % | 0.50 % |
N/A |
USD 0.39B |
HPF:CA | Energy Leaders Plus Incom.. | 0.00 % | 1.74 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Biotechnology) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -99.77% | 1% | F | N/A | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -99.77% | 1% | F | N/A | F | ||
Trailing 12 Months | |||||||
Capital Gain | -99.80% | 2% | F | 1% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -99.80% | 2% | F | 1% | F | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | -64.06% | 1% | F | N/A | F | ||
Dividend Return | -64.06% | 1% | F | N/A | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 40.96% | 73% | C | 57% | F | ||
Risk Adjusted Return | -156.42% | 2% | F | N/A | F | ||
Market Capitalization | 4.21K | 8% | B- | 5% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total free cash flow in the most recent four quarters.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.